Voltage-clamp evidence of GABAA receptor subunit-specific effects: pharmacodynamic fingerprint of chlornordiazepam, the major active metabolite of mexazolam, as compared to alprazolam, bromazepam, and zolpidem-Reference-Cited by-同舟云学术

Voltage-clamp evidence of GABAA receptor subunit-specific effects: pharmacodynamic fingerprint of chlornordiazepam, the major active metabolite of mexazolam, as compared to alprazolam, bromazepam, and zolpidem

Published:2022-09-12 Issue:5 Volume:74 Page:956-968
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacol. Rep

Author:

Fernandes Hélder^ORCID,Batalha Vânia,Braksator Ellen,Hebeisen Simon,Bonifácio Maria João,Vieira-Coelho Maria Augusta,Soares-da-Silva Patrício

Funder

BIAL

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s43440-022-00411-x.pdf

Reference49 articles.

1. Olsen R, Sieghart W. International union of pharmacology. LXX. Subtypes of γ-aminobutyric AcidA receptores: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev. 2008;60(3):243–59.

2. Stahl SM. Anxiety disorders and anxiolytics (chapter 9). In: Stahl’s essential psychopharmacology: neuroscientific basis and practical applications. forth. New York: Cambridge University Press; 2013. p. 388–419.

3. Graham D, Faure G, Besnard F, Langer SZ. Pharmacological profile of benzodiazepine site ligands wit recombinant GABAA receptor subtypes. Eur Neuropsychopharmacol. 1996;6(2):119–25.

4. Harrison NL. Mechanisms of sleep induction by GABA(A) receptor agonists. J Clin Psychiatry. 2007;68(Suppl5):6–12.

5. Cheng T, Wallace DM, Ponteri B, Tuli M. Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects. Neuropsychiatry Dis Treat. 2018;14:1351–61.